Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Therapeutic drug monitoring in rheumatic diseases: utile or futile?

rheumatic diseases

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 15 January 2014 - 01:11 PM

Therapeutic drug monitoring in rheumatic diseases: utile or futile?

 

The therapeutic effect of most medications may be slow to manifest and studies in rheumatic diseases have so far failed to confirm a useful association between concentrations and disease control or drug toxicity. PubMed, Rheumatology, 2013 Nov 5. (Also see: Rheumatic Diseases)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: rheumatic diseases